These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32470213)

  • 41. High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia.
    Minuz P; Mansueto G; Mazzaferri F; Fava C; Dalbeni A; Ambrosetti MC; Sibani M; Tacconelli E
    Clin Microbiol Infect; 2020 Nov; 26(11):1572-1573. PubMed ID: 32565320
    [No Abstract]   [Full Text] [Related]  

  • 42. COVID-19 and Hypercoagulability.
    Sholzberg M
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.
    Léonard-Lorant I; Delabranche X; Séverac F; Helms J; Pauzet C; Collange O; Schneider F; Labani A; Bilbault P; Molière S; Leyendecker P; Roy C; Ohana M
    Radiology; 2020 Sep; 296(3):E189-E191. PubMed ID: 32324102
    [No Abstract]   [Full Text] [Related]  

  • 44. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.
    Rieder M; Goller I; Jeserich M; Baldus N; Pollmeier L; Wirth L; Supady A; Bode C; Busch HJ; Schmid B; Duerschmied D; Gauchel N; Lother A
    J Thromb Thrombolysis; 2020 Oct; 50(3):558-566. PubMed ID: 32617807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
    Magro G
    Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
    [No Abstract]   [Full Text] [Related]  

  • 46. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.
    Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ
    Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008
    [No Abstract]   [Full Text] [Related]  

  • 47. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 48. High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19.
    Chapman AR; Bularga A; Mills NL
    Circulation; 2020 Jun; 141(22):1733-1735. PubMed ID: 32251612
    [No Abstract]   [Full Text] [Related]  

  • 49. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 50. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 51. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
    Wanderer JP; Nathan N
    Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
    [No Abstract]   [Full Text] [Related]  

  • 52. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
    Bilaloglu S; Aphinyanaphongs Y; Jones S; Iturrate E; Hochman J; Berger JS
    JAMA; 2020 Aug; 324(8):799-801. PubMed ID: 32702090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
    Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
    Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.
    Adam EH; Schmid B; Sonntagbauer M; Kranke P; Zacharowski K; Meybohm P
    Crit Care; 2020 Sep; 24(1):574. PubMed ID: 32972429
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe COVID-19 Is a Microvascular Disease.
    Lowenstein CJ; Solomon SD
    Circulation; 2020 Oct; 142(17):1609-1611. PubMed ID: 32877231
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19.
    Martinelli N; Montagnana M; Pizzolo F; Friso S; Salvagno GL; Forni GL; Gianesin B; Morandi M; Lunardi C; Lippi G; Polati E; Olivieri O; De Franceschi L
    Thromb Res; 2020 Sep; 193():170-172. PubMed ID: 32707276
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
    Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genetic sequence, origin, and diagnosis of SARS-CoV-2.
    Wang H; Li X; Li T; Zhang S; Wang L; Wu X; Liu J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1629-1635. PubMed ID: 32333222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19.
    Bousquet G; Falgarone G; Deutsch D; Derolez S; Lopez-Sublet M; Goudot FX; Amari K; Uzunhan Y; Bouchaud O; Pamoukdjian F
    Aging (Albany NY); 2020 Jun; 12(12):11306-11313. PubMed ID: 32576712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.